human coronavirus;
seroepidemiology;
nucleocapsid;
D O I:
10.1016/j.jcv.2007.08.007
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
Background: Recently, several new human coronaviruses have been identified. Objectives: To define the seroepidemiology of group I human coronaviruses. Study design: A recombinant protein enzyme linked immunosorbent assay (ELISA) based on portions of the nucleocapsid protein of group I human coronaviruses was developed and was used to screen serum from 243 children and young adults. Results: For HCoV-229E, the percentages of seropositive individuals were 57. 1 % for infants <2 months old; 38.9% for infants 2-3 months old; 4.7% for infants 4-5 months old; 42.9-50.0% for infants 6-12 months old; 34.8-62.5% for individuals 1-20 years old. For HCoV-NL63, the percentages of seropositive individuals were 45.2% for infants <2 months old; 11. 1% for infants 2-3 months old; 4.7% for infants 4-5 months old; 28.6-40.0% for infants 6-12 months old; 25.0-70.3% for individuals 1-20 years old. Conclusions: Infection with these viruses is common in childhood though the prevalence of these viruses may vary from year to year. (C) 2007 Elsevier B.V. All rights reserved.
机构:
Womens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia
Univ Adelaide, Robinson Res Inst, Adelaide, SA, AustraliaWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Marshall, Helen S.
Richmond, Peter
论文数: 0引用数: 0
h-index: 0
机构:
Univ Western Australia, Sch Paediat & Child Hlth, Subiaco, WA, Australia
Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Vaccine Trials Grp, Subiaco, WA, AustraliaWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Richmond, Peter
Nissen, Michael
论文数: 0引用数: 0
h-index: 0
机构:
Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia
Univ Queensland, Royal Childrens Hosp, Brisbane, Qld, AustraliaWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Nissen, Michael
论文数: 引用数:
h-index:
机构:
Lambert, Stephen
Booy, Robert
论文数: 0引用数: 0
h-index: 0
机构:
Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Westmead, NSW, Australia
Univ Sydney, Marie Bashir Inst, Sydney, NSW 2006, AustraliaWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Booy, Robert
Reynolds, Graham
论文数: 0引用数: 0
h-index: 0
机构:
ANU Med Sch, Canberra Hosp, Dept Paediat & Child Hlth, Canberra, ACT, AustraliaWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Reynolds, Graham
Sebastian, Shite
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Vaccine Res, Pearl River, NY USAWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Sebastian, Shite
Pride, Michael
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Vaccine Res, Pearl River, NY USAWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Pride, Michael
Jansen, Kathrin U.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Vaccine Res, Pearl River, NY USAWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Jansen, Kathrin U.
Anderson, Annaliesa S.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Vaccine Res, Pearl River, NY USAWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia
Anderson, Annaliesa S.
Scully, Ingrid L.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Vaccine Res, Pearl River, NY USAWomens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit, Adelaide, SA 5006, Australia